Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 419

1.

Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.

Chen JL, Huang CY, Huang YS, Chen RJ, Wang CW, Chen YH, Cheng JC, Cheng AL, Kuo SH.

Acta Obstet Gynecol Scand. 2014 Jul;93(7):661-8. doi: 10.1111/aogs.12383.

PMID:
24666257
2.

Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.

Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013.

PMID:
22365621
3.

Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).

Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, Kim JY, Huh SJ.

Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043.

PMID:
24486605
4.

Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma.

Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY.

Acta Obstet Gynecol Scand. 2012 Oct;91(10):1158-66. doi: 10.1111/j.1600-0412.2012.01420.x.

PMID:
22497449
5.

Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.

Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA.

Cancer. 2003 May 1;97(9):2196-202. Review.

6.

Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.

Hong JH, Tsai CS, Wang CC, Lai CH, Chen WC, Lee SP, Chang TC, Tseng CJ.

Chang Gung Med J. 2000 Jul;23(7):396-404.

PMID:
10974754
7.

Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.

Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2012 Oct;22(8):1389-97.

PMID:
22976497
8.

Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.

Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. Review.

PMID:
12654434
9.

Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.

Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Hsueh S, Chen CK, Lee SP, Hong JH.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):429-36. doi: 10.1016/j.ijrobp.2010.02.009.

PMID:
20542643
10.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
11.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.

Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029.

PMID:
18977518
12.
13.

Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H.

Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1309-17.

PMID:
7635770
15.

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.

Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S.

Gynecol Oncol. 2012 May;125(2):292-6. doi: 10.1016/j.ygyno.2012.01.034.

PMID:
22293041
16.

Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.

Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T.

Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021.

PMID:
22728518
17.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
18.

Does histology influence prognosis in patients with early-stage cervical carcinoma?

Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B.

Cancer. 2001 Dec 15;92(12):2999-3004.

PMID:
11753977
19.

Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.

King M, McConkey C, Latief TN, Hartley A, Fernando I.

Clin Oncol (R Coll Radiol). 2006 Feb;18(1):38-45. Erratum in: Clin Oncol (R Coll Radiol). 2006 May;18(4):368.

PMID:
16477918
20.

High dose-rate brachytherapy for elderly patients with uterine cervical cancer.

Chen SW, Liang JA, Yang SN, Lin FJ.

Jpn J Clin Oncol. 2003 May;33(5):221-8.

Items per page

Supplemental Content

Support Center